Cannon Gillian bought CORT
September 4, 2025 · Form 4 insider transaction
Cannon Gillian bought 11,000 shares of Corcept Therapeutics Incorporated at $22.99 per share, a transaction worth $252.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
11,000
Price
$22.99
Total value
$252.9K
InsiderCannon Gillian
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 4, 2025
Filing dateSeptember 8, 2025
Shares owned after11,000
OwnershipDirect
10b5-1 planNo
AmendedNo